DOI: 10.31274/rtd-180813-6326
|View full text |Cite
|
Sign up to set email alerts
|

Unified model studies of N=84 and N=80 nuclei

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…Several researchers have built on these findings, and many transition metal complexes have since been reported to efficiently catalyze ATRP using visible light. 15,16 More recently, organic photoredox catalysts 17 (PCs) based on perylene, 18 phenothiazine, 19 dihydrophenazine, 20 and phenoxazine 21 chromophore motifs have been developed to mediate organocatalyzed ATRP (O-ATRP) to produce polymers with controlled MW, high initiator efficiency (I* = MW theo /MW exp ), and low Đ ( Figure 1) while avoiding the possibility for incorporating metal contamination into the polymer product. 22,23 Since the seminal reports on O-ATRP, PC structural modifications, 24 photophysical characterizations, [25][26][27] solvent effects, 28 light intensity modulations, 29 and synthesis of higher-order polymer architectures [30][31][32] have been reported to advance the O-ATRP processes.…”
Section: Introductionmentioning
confidence: 99%
“…Several researchers have built on these findings, and many transition metal complexes have since been reported to efficiently catalyze ATRP using visible light. 15,16 More recently, organic photoredox catalysts 17 (PCs) based on perylene, 18 phenothiazine, 19 dihydrophenazine, 20 and phenoxazine 21 chromophore motifs have been developed to mediate organocatalyzed ATRP (O-ATRP) to produce polymers with controlled MW, high initiator efficiency (I* = MW theo /MW exp ), and low Đ ( Figure 1) while avoiding the possibility for incorporating metal contamination into the polymer product. 22,23 Since the seminal reports on O-ATRP, PC structural modifications, 24 photophysical characterizations, [25][26][27] solvent effects, 28 light intensity modulations, 29 and synthesis of higher-order polymer architectures [30][31][32] have been reported to advance the O-ATRP processes.…”
Section: Introductionmentioning
confidence: 99%
“…Doctor-patient interaction takes place in a social context characterised by relationships of power, trust, and dependence, which have a significant impact on the practical ability of patients to exercise autonomous choice. 109 As scholars of clinical ethics have long been aware, conceptions of consent rooted primarily in autonomy are inherently limited in their ability to deal with inequality. Two assumptions underlie these models: firstly, that patients who are given scientific information on the benefits and risks of treatment can make decisions for themselves and, secondly, that 'physicians should not have an investment in the decisionmaking process or in the decision made.'…”
Section: B Passive Subjects and Active Choices: The Social Context Of...mentioning
confidence: 99%